A University of Sharjah-College of Pharmacy student, partly sponsored by leading pharmaceutical company Boehringer Ingelheim, has won two awards at the annual Think Science Competition, which is organised by Emirates Foundation for Youth Develop
Boehringer Ingelheim, a leading pharmaceutical company, has unveiled the new DDP-4 inhibitor treatment for those with type 2 diabetes, which is the most common form of diabetes often leading to chronic complications like cardiovascular, kidney a
Germany-based Boehringer Ingelheim, a top research-driven pharmaceutical company, has recorded a sales growth of 14.3 per cent during the first half of the year in the Mena region.
Net global sales rose by 3.1 per cent, currency-a
Boehringer Ingelheim and Eli Lilly and Company today announced a global agreement to jointly develop and commercialise a portfolio of diabetes compounds currently in mid- and late-stage development.
Included are Boehringer Ingelheim’s two